ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Survival benefit with proapoptotic molecular and pathologic responses from dual targeting of mammalian target of rapamycin and epidermal growth factor receptor in a preclinical model of pancreatic neuroendocrine carcinogenesis.

Christopher W Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.